Literature DB >> 8279773

The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group.

R Gray1, M Clarke, R Collins, R Peto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8279773     DOI： 10.1111/j.1749-6632.1993.tb17224.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Clinical trial results applied to management of the individual cancer patient.

Authors:  Ismail Jatoi; Michael A Proschan
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Adjuvant treatment with tamoxifen. Informed consent and follow up in aTTom trial are inadequate.

Authors:  H Cunningham
Journal:  BMJ       Date:  1996-08-24

3.  Impact of Treatment Type on Overall Survival in ElderlyBrazilian Women with Breast Cancer

Authors:  Marcelo Adeodato Bello; Raquel Ferreira de Menezes; Brunna Silva; Rafael de Carvalho da Silva; Rousiane Silva Cavalcanti; Thayane de Fátima da Costa Moraes; Fabiana Tonellotto; Suzana Sales de Aguiar; Renata Brum Martucci; Anke Bergmann; Luiz Claudio Thuler
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

4.  Impact of body mass index, weight gain, and metabolic disorders on survival and prognosis in patients with breast cancer who underwent chemotherapy.

Authors:  Ping Yang; Yingjian He; Xinying Yu; Baohua Liu; Xuemei Wang; Xiangping Li; Peiyu Wang
Journal:  Chin Med J (Engl)       Date:  2022-03-10       Impact factor: 6.133
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.